Filings

6 documents · 37 matches

1. FDMT 4D Molecular Therapeutics, Inc. 10-Q 2026-08-13

   Item 1A. Risk Factors.

   tariffs on pharmaceutical manufacturers that do not adopt pricing policies such as most favored nation pricing, which would tie the price
   7 matches in this document Show context Copy citation

2. FDMT 4D Molecular Therapeutics, Inc. 10-Q 2026-05-07

   Item 1 · Note 2. Summary of Significant Accounting Policies

   tariffs and inflation, natural disasters and health crises, such as pandemics, there has been uncertainty and disruption in the global
   7 matches in this document Show context Copy citation

3. FDMT 4D Molecular Therapeutics, Inc. 10-K 2026-03-18

   Item 1. Business.

   tariffs on pharmaceutical manufacturers that do not adopt pricing policies such as most favored nation pricing, which would tie the price
   8 matches in this document Show context Copy citation

4. FDMT 4D Molecular Therapeutics, Inc. 10-Q 2025-11-10

   Item 1 · Note 2. Summary of Significant Accounting Policies

   tariffs and inflation, natural disasters and health crises, such as pandemics, there has been uncertainty and disruption in the global
   5 matches in this document Show context Copy citation

5. FDMT 4D Molecular Therapeutics, Inc. 10-Q 2025-08-11

   Item 1 · Note 2. Summary of Significant Accounting Policies

   tariffs and inflation, natural disasters and health crises, such as pandemics, there has been uncertainty and disruption in the global
   5 matches in this document Show context Copy citation

6. FDMT 4D Molecular Therapeutics, Inc. 10-Q 2025-05-08

   Item 1 · Note 2. Summary of Significant Accounting Policies

   tariffs and inflation, natural disasters and health crises, such as pandemics, there has been uncertainty and disruption in the global
   5 matches in this document Show context Copy citation